While HMOX1 protein levels were significantly higher in the simvastatin-treated group (p < 0.05), the expression of the NRF2 target genes HMOX1, NQO1, and GCLM in AAA tissue did not show significant differences between the treated and untreated groups [52]. Here, GCLM is linked to triple-A syndrome.